The ReFlow™ System Mini and ReFlow™ Mini Flusher are 510 (k) cleared by the U.S. FDA for use in the treatment of hydrocephalus as a part of a CSF shunt system.

A shunt would not be indicated quite yet. In people with an MRI showing hydrocephalus and compatible symptoms, a lumbar puncture is performed.

Dublin, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The "Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update ...

Dublin, April 26, 2023 (GLOBE NEWSWIRE) -- The "Hydrocephalus Shunts - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's ...

The global hydrocephalus shunts market was valued at $291.00 million in 2019 and is projected to reach $322.01 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Growth in the number of ...

Future Market Insights, a renowned provider of industry analysis, has released its latest report unveiling promising projections for the global hydrocephalus shunt market. According to the analysis, ...

Summary Hydrocephalus Shunts (Neurology Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Neurology Devices ...

Summary Hydrocephalus Shunts (Neurology Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Neurology Devices ...

Why shunts fail TerMaath's hydrocephalus is caused by a cyst blocking the flow of fluid. The shunt was a last resort, after other attempts to treat the condition failed.